These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19274418)

  • 21. Therapeutic Effect of MK2 Inhibitor on Experimental Murine Dry Eye.
    Wu Y; Bu J; Yang Y; Lin X; Cai X; Huang C; Zheng X; Ouyang W; Li W; Zhang X; Liu Z
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4898-4907. PubMed ID: 28973340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transdermal anti-inflammatory therapy for aqueous deficiency.
    McMonnies CW
    Ophthalmic Physiol Opt; 2021 Nov; 41(6):1267-1272. PubMed ID: 34605579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model.
    Seo MJ; Kim JM; Lee MJ; Sohn YS; Kang KK; Yoo M
    Curr Eye Res; 2010 Feb; 35(2):165-75. PubMed ID: 20136427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Emphasizing the prevention and anti-inflammation research of dry eye disease].
    Zhang MC; Bian F
    Zhonghua Yan Ke Za Zhi; 2013 Jan; 49(1):6-7. PubMed ID: 23601457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vivo Anti-Inflammation Potential of
    Hong SC; Ha JH; Lee JK; Jung SH; Kim JC
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33113960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study.
    Avunduk AM; Avunduk MC; Varnell ED; Kaufman HE
    Am J Ophthalmol; 2003 Oct; 136(4):593-602. PubMed ID: 14516798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of dry eye disease.
    Lemp MA
    Am J Manag Care; 2008 Apr; 14(3 Suppl):S88-101. PubMed ID: 18452372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymosin Beta 4: A Potential Novel Therapy for Neurotrophic Keratopathy, Dry Eye, and Ocular Surface Diseases.
    Sosne G; Rimmer D; Kleinman HK; Ousler G
    Vitam Horm; 2016; 102():277-306. PubMed ID: 27450739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
    Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
    Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restasis use in the chronic dry eye patient.
    Bataoel A
    Insight; 2007; 32(3):21. PubMed ID: 17953324
    [No Abstract]   [Full Text] [Related]  

  • 31. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine.
    Kunert KS; Tisdale AS; Gipson IK
    Arch Ophthalmol; 2002 Mar; 120(3):330-7. PubMed ID: 11879137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
    Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline.
    De Paiva CS; Corrales RM; Villarreal AL; Farley W; Li DQ; Stern ME; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2847-56. PubMed ID: 16799024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone nanowafer as an effective therapy for dry eye disease.
    Coursey TG; Henriksson JT; Marcano DC; Shin CS; Isenhart LC; Ahmed F; De Paiva CS; Pflugfelder SC; Acharya G
    J Control Release; 2015 Sep; 213():168-174. PubMed ID: 26184051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Trabodenoson in a Mouse Keratoconjunctivitis Sicca (KCS) Model for Dry-Eye Syndrome.
    Žiniauskaite A; Ragauskas S; Hakkarainen JJ; Rich CC; Baumgartner R; Kalesnykas G; Albers DS; Kaja S
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3088-3093. PubMed ID: 30025146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory Response in Dry Eye.
    Yamaguchi T
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES192-DES199. PubMed ID: 30481826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjunctivochalasis: a systematic review.
    Marmalidou A; Kheirkhah A; Dana R
    Surv Ophthalmol; 2018; 63(4):554-564. PubMed ID: 29128574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of cyclosporine 0.05% in various ocular surface disorders].
    Maĭchuk DIu; Vasil'eva OA; Shokirova MM
    Vestn Oftalmol; 2014; 130(2):68-71. PubMed ID: 24864503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory Response to Lipopolysaccharide on the Ocular Surface in a Murine Dry Eye Model.
    Simmons KT; Xiao Y; Pflugfelder SC; de Paiva CS
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2443-51. PubMed ID: 27136463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex hormones and the dry eye.
    Truong S; Cole N; Stapleton F; Golebiowski B
    Clin Exp Optom; 2014 Jul; 97(4):324-36. PubMed ID: 24689906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.